Guided Therapeutics (GTHP) EBT Margin Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Dec 31, 2024 | -6.45 Mn |
| Dec 31, 2023 | -987,025.00 |
| Sep 30, 2022 | -2.41 Mn |
| Jun 30, 2022 | 24.78 Mn |
| Mar 31, 2022 | -894,556.00 |
| Dec 31, 2021 | 578,857.00 |
| Sep 30, 2021 | 3.77 Mn |
| Jun 30, 2021 | -9.45 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Sep 30, 2020 | 921,212.00 |
| Dec 31, 2019 | 635,517.00 |
| Sep 30, 2019 | -1.24 Mn |
| Dec 31, 2018 | 1.30 Mn |
| Sep 30, 2018 | -991,250.00 |
| Jun 30, 2018 | 5.98 Mn |
| Mar 31, 2018 | 3.54 Mn |
| Dec 31, 2017 | -13.56 Mn |
| Sep 30, 2017 | 634,242.00 |
| Jun 30, 2017 | 1.83 Mn |
| Mar 31, 2017 | -873,058.00 |
| Dec 31, 2016 | -22,602.00 |
| Sep 30, 2016 | -189,420.00 |
| Dec 31, 2015 | -1.97 Mn |
| Sep 30, 2015 | -2.75 Mn |
| Jun 30, 2015 | -1.69 Mn |
| Mar 31, 2015 | -844,109.00 |
| Dec 31, 2014 | 12.71 Mn |
| Sep 30, 2014 | -1.38 Mn |
| Jun 30, 2014 | -1.96 Mn |
| Mar 31, 2014 | 812,640.00 |
| Jun 30, 2013 | 85,077.00 |